JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
|
+$1.79B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.72B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.6B |
| 4 |
Deere & Co
DE
|
+$1.34B |
| 5 |
Amazon
AMZN
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$1.61B |
| 2 |
Tesla
TSLA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.51B |
| 4 |
Salesforce
CRM
|
+$1.32B |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.65% |
| 2 | Technology | 15.75% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Healthcare | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4276
IDEAYA Biosciences
IDYA
$3.65B
| $749K | ﹤0.01% |
31,850
-44,840
| -58% | -$866K |
2020 Q2
3 quarters
|
|
4277
First Trust Rising Dividend Achievers ETF
RDVY
$25.1B
| $748K | ﹤0.01% |
16,435
+3,670
| +29% | +$156K |
2017 Q3
14 quarters
|
|
4278
iShares US Regional Banks ETF
IAT
$606M
| $747K | ﹤0.01% |
13,190
-37,083
| -74% | -$1.96M |
2020 Q1
4 quarters
|
|
|
IHC
4279
DELISTED
Independence Holding Company
IHC
| $745K | ﹤0.01% |
18,700
-449
| -2% | -$18.3K |
2017 Q4
13 quarters
|
|
4280
WisdomTree US SmallCap Dividend Fund
DES
$2.06B
| $744K | ﹤0.01% |
23,876
+7,922
| +50% | +$234K |
2013 Q2
31 quarters
|
|
4281
MetroCity Bankshares
MCBS
$998M
| $743K | ﹤0.01% |
48,272
+932
| +2% | +$14K |
2019 Q4
5 quarters
|
|
|
CTO
4282
CTO Realty Growth
CTO
$763M
| $742K | ﹤0.01% |
42,801
-6,159
| -13% | -$99.7K |
2017 Q4
13 quarters
|
|
|
UBX
4283
DELISTED
Unity Biotechnology
UBX
| $739K | ﹤0.01% |
12,306
+1,933
| +19% | +$132K |
2018 Q2
11 quarters
|
|
4284
Alta Equipment Group
ALTG
$206M
| $737K | ﹤0.01% |
56,720
+1,590
| +3% | +$17.3K |
2020 Q2
3 quarters
|
|
4285
PUT
Dominion Energy
D
$53.4B
| $737K | ﹤0.01% |
+9,700
| New | +$705K |
2021 Q1
0 quarters
|
|
|
TRHC
4286
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $737K | ﹤0.01% |
16,012
+4,969
| +45% | +$237K |
2017 Q3
14 quarters
|
|
|
HBMD
4287
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $736K | ﹤0.01% |
44,769
+5,863
| +15% | +$83.9K |
2017 Q2
15 quarters
|
|
4288
Coastal Financial
CCB
$620M
| $735K | ﹤0.01% |
28,045
+1,160
| +4% | +$28.7K |
2018 Q3
10 quarters
|
|
4289
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.32B
| $733K | ﹤0.01% |
11,513
| – | – |
2013 Q4
29 quarters
|
|
4290
ALX Oncology
ALXO
$180M
| $732K | ﹤0.01% |
9,932
+4,838
| +95% | +$381K |
2020 Q3
2 quarters
|
|
4291
Cohen & Steers Duration Preferred & Income Fund
LDP
$564M
| $732K | ﹤0.01% |
28,008
+559
| +2% | +$14.3K |
2017 Q2
15 quarters
|
|
|
USX
4292
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $730K | ﹤0.01% |
62,068
+52,259
| +533% | +$481K |
2018 Q2
11 quarters
|
|
4293
Global X Copper Miners ETF NEW
COPX
$7.14B
| $729K | ﹤0.01% |
20,512
-14,197
| -41% | -$494K |
2019 Q3
6 quarters
|
|
|
SRGA
4294
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $727K | ﹤0.01% |
11,124
+5,175
| +87% | +$361K |
2017 Q4
13 quarters
|
|
|
EVLO
4295
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $726K | ﹤0.01% |
3,396
+777
| +30% | +$215K |
2018 Q2
11 quarters
|
|
4296
Invesco Financial Preferred ETF
PGF
$616M
| $724K | ﹤0.01% |
38,315
+15,697
| +69% | +$294K |
2014 Q1
28 quarters
|
|
4297
Travere Therapeutics
TVTX
$5.36B
| $724K | ﹤0.01% |
28,986
-6,923
| -19% | -$191K |
2016 Q4
17 quarters
|
|
4298
PUT
ALPS REIT Dividend Dogs ETF
RDOG
$10.3M
| $723K | ﹤0.01% |
+23,700
| New | +$1.01M |
2021 Q1
0 quarters
|
|
|
MCBC
4299
DELISTED
Macatawa Bank Corp
MCBC
| $723K | ﹤0.01% |
72,705
-3,277
| -4% | -$30.1K |
2015 Q4
21 quarters
|
|
|
SMTS
4300
DELISTED
Sierra Metals Inc. Common Stock
SMTS
| $723K | ﹤0.01% |
229,633
+225,835
| +5,946% | +$711K |
2020 Q4
1 quarter
|
|
Similar funds
JP Morgan Chase's Q1 2021 Portfolio in Review
As of Q1 2021, JP Morgan Chase held 6,599 positions worth $749B, up 10% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q1 2021, opening 866 new positions and adding to 2,869 existing holdings. Its largest new stake was Ferguson: 4,925,283 shares worth $592M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $1.61B trimmed.
- JP Morgan Chase's largest Q1 2021 buy was Ferguson: 4,925,283 shares worth $592M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF in Q1 2021, an estimated $1.79B increase.
- JP Morgan Chase's biggest Q1 2021 reduction was iShares TIPS Bond ETF, cutting an estimated $1.61B.
- JP Morgan Chase fully exited TC Pipelines LP in Q1 2021, selling an estimated $65.2M.
- JP Morgan Chase's ten largest holdings make up 15% of its $749B portfolio in Q1 2021.
- JP Morgan Chase opened 866 new positions and closed 461 in Q1 2021.
- JP Morgan Chase's portfolio value rose 10% quarter-over-quarter to $749B.
Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.